BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Targets/CYP2C9/Compounds

Compounds That Target CYP2C9

cytochrome P450 family 2 subfamily C member 9 · 436 compounds in BiohacksAI corpus

CYP2C9 (cytochrome P450 family 2 subfamily C member 9) is a cytochrome P450 enzyme involved in the metabolism of drugs, hormones, and dietary compounds. CYP enzymes are critical determinants of pharmacokinetics and drug-herb interactions. The 436 compounds listed here have documented interactions with CYP2C9 based on BindingDB inhibition and binding assay data, making this resource valuable for assessing compound safety and interaction profiles.

View CYP2C9 target page →
Most Studied Compounds for CYP2C9
1
Budesonide
1.0k+
studies
2
Sulfaphenazole
300+
studies
3
Norgestrel
300+
studies
4
Phenylbutazone
300+
studies
5
Daidzein
300+
studies
6
Quercetin
300+
studies
7
Emodin
300+
studies
8
Hexachlorophene
300+
studies
9
Mestranol
300+
studies
10
Methoxypsoralen
300+
studies
All 50 Compounds — Ranked by Evidence
1
Sb 203580
4.92
confidence
2
Sirolimus
4.82
confidence
3
Raloxifene
4.77
confidence
4
Nimodipine
4.29
confidence
5
Benzbromarone
4.13
confidence
6
Sulfaphenazole
300+
studies
4.11
confidence
7
Zafirlukast
3.89
confidence
8
Felodipine
3.85
confidence
9
Venetoclax
3.69
confidence
10
Dicumarol
3.56
confidence
11
Navitoclax
3.53
confidence
12
Candesartan
3.47
confidence
13
Idebenone
3.22
confidence
14
Closantel
2.71
confidence
15
Liarozole
2.71
confidence
16
Disulfiram
297+
studies
2.56
confidence
17
Bisacodyl
2.56
confidence
18
Clotrimazoleheterocyclic
2.48
confidence
19
Sulconazole
2.48
confidence
20
Oxiconazole
2.48
confidence
21
Glyburide
298+
studies
2.40
confidence
22
Phenytoinheterocyclic
2.40
confidence
23
Lacidipine
2.40
confidence
24
Gemfibrozil
297+
studies
2.30
confidence
25
Levonorgestrel
292+
studies
2.30
confidence
26
Norgestrel
300+
studies
2.30
confidence
27
Tenidap
2.30
confidence
28
Celecoxib
295+
studies
2.20
confidence
29
Finasteride
296+
studies
2.20
confidence
30
Phenylbutazone
300+
studies
2.20
confidence
31
Mosapride
2.20
confidence
32
Daidzein
300+
studies
2.08
confidence
33
Quercetin
300+
studies
2.08
confidence
34
Chlorhexidine
299+
studies
2.08
confidence
35
Danazol
298+
studies
2.08
confidence
36
Emodin
300+
studies
2.08
confidence
37
Fenofibrate
297+
studies
2.08
confidence
38
Flutamide
298+
studies
2.08
confidence
39
Fulvestrant
295+
studies
2.08
confidence
40
Hexachlorophene
300+
studies
2.08
confidence
41
Loratadine
296+
studies
2.08
confidence
42
Meloxicam
299+
studies
2.08
confidence
43
Mestranol
300+
studies
2.08
confidence
44
Methoxypsoralen
300+
studies
2.08
confidence
45
Niclosamideorganic
2.08
confidence
46
Rotenone
300+
studies
2.08
confidence
47
Budesonide
1.0k+
studies
1.95
confidence
48
Dhea
300+
studies
1.95
confidence
49
Progesterone
299+
studies
1.95
confidence
50
Acetohexamide
217+
studies
1.95
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CYP2C9 (cytochrome P450 family 2 subfamily C member 9). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CYP2C9 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.